Jose Luis came to Central Florida with his family four years ago on a tourist visa. Now he and his wife are building a new ...

Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...